Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
1.2100
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 14th, 4:59 AM EST
Detailed Quote
Previous Close
1.210
Open
-
Bid
1.160
Ask
1.190
Day's Range
N/A - N/A
52 Week Range
0.9100 - 108.00
Volume
18,786
Market Cap
54.18M
PE Ratio (TTM)
-0.4172
EPS (TTM)
-2.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
4,061,005
Chart
About Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
Salarius Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for cancer patients. The company specializes in the research and development of novel drug candidates that target specific epigenetic mechanisms to combat various forms of cancer. By harnessing the potential of these targeted therapies, Salarius aims to improve treatment outcomes and minimize side effects for patients. The company's approach emphasizes precision medicine, with a commitment to addressing unmet medical needs in oncology through robust scientific innovation and clinical trials. Read More
The Viral Threat Hiding in Plain Sight: Between August 2024 and July 2025, the CDC’s NoroSTAT system recorded 2,675 norovirus outbreaks across the United States. A genetic shift has emerged: the GII.17 strain has overtaken the long-dominant GII.4 lineage , now responsible for roughly 75 percent of reported cases . Health officials warn this strain replacement increases outbreak frequency and severity, as current cleaning and immunity defenses are quickly becoming outdated. Why It Matters
Nika Pharmaceuticals, Inc. (OTCQB: NIKA ), a next-generation biopharmaceutical company focused on immune-strengthening therapeutics, is emerging as a compelling investment opportunity in the global fight against HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, and Diabetes . With a robust pipeline of proprietary drugs and supplements designed to enhance cellular immunity, NIKA is positioned to address multi-billion-dollar markets in both pharmaceuticals and nutraceuticals .
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
